Since the (partial) loss of conventional melanocytic markers in primary melanomas and metastases with rhabdoid differentiation makes histopathologic diagnosis challenging, additional immunostaining for PRAME could facilitate diagnosis. The gene discussed is PRAME; the disease is melanoma.